MediOrbis, a multi-specialty telemedicine and telehealth company with a first-of-its-kind chronic disease management (CDM) program, announces expanded access to its specialty physician network, comprehensive telemedicine services and the expansion of their co-branded, cutting-edge, digital and telehealth technology platform with MediGuide, a global concierge medical second opinion (MSO) company serving millions of members across 50+ countries globally. Building on this longtime strategic and collaborative relationship, MediGuide members now have expanded access to the extensive portfolio of MediOrbis capabilities, including:
- Artificial Intelligence (AI)-based software platform, mobile apps, reporting and database programs, EHR, and telemedicine carts.
- The MediOrbis extensive network of outstanding, highly trained physicians who will provide clinical services to support global medical second opinion and telemedicine services.
- Underway in 2020: participation with MediOrbis clinical programs, such as specialty and chronic disease management (CDM).
“This unique, advanced technology platform and extraordinary network of some of the most highly qualified medical specialists further establishes MediOrbis as the leading specialty telemedicine company worldwide,” says Dr. Jonathan Wiesen, M.D., founder and chief medical officer, MediOrbis, and pulmonary specialist with advanced training in critical care and medical ethics. “We are pleased to provide MediGuide members with the vast benefits of sophisticated telehealth technology, and look forward to introducing additional innovative services, such as CDM, in the coming months. For 20+ years, MediGuide has become a recognized pioneer and front-runner in second opinion services, and we are honored and gratified with this expanded partnership.”
“Results can also be measured in terms of higher quality care, reduced hospital admissions and lower costs,” says Wiesen. “Our team of MediOrbis U.S.-trained, board certified, licensed and credentialed specialty physicians will also provide members with a holistic review of medical information regarding their specific conditions, surpassing the scope of facts and data typically available from a single physician review.”
The MediGuide MSO program has long been one of the most outstanding and cost-effective solutions in the space. Their strategic partnership with MediOrbis is regarded as a catalyst for providing MediGuide members with an end to end cost effective clinical services, spanning all ailments from the most simple to the most complex.
Paul Vermeulen, CEO, MediGuide, states, “With more than 70% of the global healthcare providers now utilizing telemedicine to connect with and treat its patients, MediGuide recognized it was time to expand its service offerings. Just like our MSO programs, this new service is exclusively open to our valued members. For less than one dollar a month, MediGuide members gain access to this invaluable service offering which also includes its remote MSO service.”
Wiesen reaffirms his commitment to the relationship, adding, “We will continue to innovate in close collaboration with MediGuide and our growing customer base, including monitoring of chronic conditions, performing triage and managing non-emergency situations. Our technology and specialty CDM program are market-changers, and the growing receptivity for these solutions is resonating among self-insured employers, hospitals, payers and brokers – especially for rural populations with limited provider availability.”
MediOrbis is a multi-specialty telemedicine and telehealth company that is shattering the barriers of traditional medicine and extending the reach of specialized clinical care and chronic disease management to its global customer base. Recognized for efficiency and cost-effectiveness to meet the needs of providers, payers and healthcare systems, MediOrbis combines AI-powered software with a network of the world’s most outstanding specialty physicians to deliver expert telemedicine services in virtually any field of medicine, clinical care or diagnostics. Visit: www.mediorbis.com.